QA: Kiniksa Pharmaceuticals International plc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001730430_2019_Kiniksa_Pharmaceuticals_International_plc.pdf

Logs

Graph

Absolute values for 0001730430, Kiniksa Pharmaceuticals International plc

  xvar xval
0 AssetsCurrent 313,750,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 6,356,000
3 remainder_Assets 1,859,000
4 LiabilitiesCurrent 42,554,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 144,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 21,563,000
9 ResearchAndDevelopmentExpense 86,597,000
10 remainder_Expenses -214,000
11 remainder_Revenues 0
12 remainder_NetIncome 4,719,000
13 remainder_ComprehensiveNetIncome -4,000
  yvar yval
0 Assets 321,965,000
1 Liabilities 42,698,000
2 Expenses 107,946,000
3 Revenues 0
4 StockholdersEquity 279,267,000
5 NetIncome -103,227,000
6 ComprehensiveNetIncome -103,229,000
7 BaseVar 238,666,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.77
9 EconomicCapitalRatio 3.54

Edgar->Model Mapping

Feature Distribution